Sanofi更新财务 以排除Opella师, 更侧重于生物药剂。 Sanofi updates financials to exclude Opella division, focusing more on biopharma.

Sanofi更新了财务报表,将Opella消费者保健司排除在外,因为该公司计划将50%的股份转给CD&R。 Sanofi has updated its financial statements to exclude its Opella consumer healthcare division, as the company plans to transfer a 50% stake to CD&R. 经审计员审查的订正数据包括销售和营业净收入,将列为已终止业务。 The revised data, reviewed by auditors, includes sales and business net income, and will be listed as discontinued operations. Sanofi的目标是更加注重生物制药。 Sanofi is aiming to focus more on biopharma. 该公司的Q4 2024调查结果反映了新的范围,将于2025年1月30日公布。 The company's Q4 2024 results, reflecting the new scope, will be released on January 30, 2025.